🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1, randomized, open label, 2 treatment, 2 period, 2-way cro...
Status
Completed
Location
Premiere Oncology
Start Date
2010-07
Trial ID
NCT01149720
Treatments Being Tested
This is a multicenter, single-arm study for safety and efficacy....
Status
Terminated
Location
Multiple Locations
Start Date
2010-02-02
Trial ID
NCT01055067
Treatments Being Tested
This is a global randomized, placebo-controlled, double-blinded Phase 2 stu...
Status
Completed
Location
Multiple Locations
Start Date
2009-09
Trial ID
NCT00988741
ARQ 197 or placebo in combination with irinotecan and cetuximab in particip...
Status
Completed
Location
Multiple Locations
Start Date
2010-01-26
Trial ID
NCT01075048
Treatments Being Tested
This is a randomized, placebo-controlled, double blind phase 2 study design...
Status
Completed
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00777309
This is an extension study that will allow participants to continue to rece...
Status
Completed
Location
Multiple Locations
Start Date
2010-08-31
Trial ID
NCT01178411
Treatments Being Tested
The purpose of this study is to determine the effects of tivantinib on the ...
Status
Completed
Location
START - South Texas Accelerated Research Therapeutics, LLC
Start Date
2011-12
Trial ID
NCT01517399
Treatments Being Tested
This will be a multi-center, open-label randomized phase 2 study designed t...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT01070290
Treatments Being Tested
This is a multi-center, open-label randomized phase 2 study designed to ass...
Status
Completed
Location
Oddzial Kliniczny Kliniki Onkologii Szpital Uniwersytecki w Krakowie
Start Date
2007-11
Trial ID
NCT00558207
Treatments Being Tested